Ken A. Olaussen
- Oncology top 1%
- Lung Cancer Research Studies 7
- PARP inhibition in cancer therapy 6
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 16
-
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 4
- Molecular Biology top 5%
- DNA Repair Mechanisms 18
- Cell death mechanisms and regulation 4
-
- Genetic factors in colorectal cancer 9
- Co-authors
- Jean‐Charles SoriaFabrice AndréLaure SabatierÉlisabeth BrambillaJean‐Pierre PignonRobert PirkerMartin FilipitsThierry Le Chevalier
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (6 papers)PLoS ONE (1 paper)
- Partner nations
- FranceAustriaUnited States
In The Last Decade
Ken A. Olaussen
53 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.7k
- Cancer Research 835
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 1.8k
- Pathology and Forensic Medicine 356
Countries citing papers authored by Ken A. Olaussen
This map shows the geographic impact of Ken A. Olaussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken A. Olaussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken A. Olaussen more than expected).
Fields of papers citing papers by Ken A. Olaussen
This network shows the impact of papers produced by Ken A. Olaussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken A. Olaussen. The network helps show where Ken A. Olaussen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ken A. Olaussen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2020 | 64 | |
| 3 | 2019 | 88 | |
| 4 | 2018 | 69 | |
| 5 | 2016 | 32 | |
| 6 | 2015 | 19 | |
| 7 | 2015 | 3 | |
| 8 | 2012 | 54 | |
| 9 | 2011 | 54 | |
| 10 | 2011 | 5 | |
| 11 | 2010 | 2 | |
| 12 | 2009 | 62 | |
| 13 | 2009 | 43 | |
| 14 | 2009 | 48 | |
| 15 | 2008 | 46 | |
| 16 | 2007 | 109 | |
| 17 | ERCC1 as Relevant Targets in the DNA Repair Pathway | 2007 | 1 |
| 18 | DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapybreakdown → | 2006 | 1320 |
| 19 | 2006 | 172 | |
| 20 | Télomères et télomérase comme cibles thérapeutiques dans le traitement du cancer | 2006 | 1 |
About Ken A. Olaussen
Ken A. Olaussen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), DNA Repair Mechanisms (18 papers), Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (9 papers), Lung Cancer Research Studies (7 papers), PARP inhibition in cancer therapy (6 papers), Cell death mechanisms and regulation (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (835 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Ken A. Olaussen has collaborated with scholars based in France, Austria and United States. Frequent co-authors include Jean‐Charles Soria, Fabrice André, Laure Sabatier, Élisabeth Brambilla, Jean‐Pierre Pignon, Robert Pirker, Martin Filipits, Thierry Le Chevalier, Pierre Fouret and Ariane Dunant. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.